TRPML1 agonist ML-SA5 attenuates pulmonary fibroblast activation by suppressing mTOR and restoring autophagic flux.
- DOI
- 10.1002/2211-5463.70346
- Published
- 2026 Sep 24
- Container
- FEBS open bio
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/2211-5463.70346,
title = {TRPML1 agonist ML-SA5 attenuates pulmonary fibroblast activation by suppressing mTOR and restoring autophagic flux.},
author = {Yao J and Kang X and Meng L and Zhang S and Li Q and Zhou J and Xue M and Li C and Zhu H and Hang P and Zhao J},
year = {2026},
journal = {FEBS open bio},
doi = {10.1002/2211-5463.70346},
url = {https://doi.org/10.1002/2211-5463.70346}
}RIS
TY - JOUR TI - TRPML1 agonist ML-SA5 attenuates pulmonary fibroblast activation by suppressing mTOR and restoring autophagic flux. AU - Yao J AU - Kang X AU - Meng L AU - Zhang S AU - Li Q AU - Zhou J AU - Xue M AU - Li C AU - Zhu H AU - Hang P AU - Zhao J PY - 2026 JO - FEBS open bio DO - 10.1002/2211-5463.70346 UR - https://doi.org/10.1002/2211-5463.70346 ER -
APA
J, Y., X, K., L, M., S, Z., Q, L., J, Z., M, X., C, L., H, Z., P, H., & J, Z. (2026). TRPML1 agonist ML-SA5 attenuates pulmonary fibroblast activation by suppressing mTOR and restoring autophagic flux.. FEBS open bio. https://doi.org/10.1002/2211-5463.70346
Source records
- pubmed · retrieved 2026-09-25T19:46:15.090Z